Evidence map›Paper›PMID 39190060›Full record

ArticleEuropean journal of trauma and emergency surgery : official publication of the European Trauma Society2024

Outcomes after open and endovascular treatment for mesenteric artery embolism patients: a retrospective inverse probability of treatment-weighted analysis.

Yi-Hui Qiu, Yin-He Zhang, Zi-Chang Wu, Zhe Yang, Guan-Xia Zhu, Shou-Liang Miao, Bi-Cheng Chen, Fan-Feng Chen

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yi-Hui Qiu *Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Nanbaixiang, Wenzhou, 325015, Zhejiang, P.R. China.
Yin-He Zhang *Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325000, China.
Zi-Chang Wu *Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325000, China.
Zhe YangThe Second Clinical Medical College, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, China.
Guan-Xia ZhuDepartment of Radiology, Longgang People's Hospital, Wenzhou, 325802, China.
Shou-Liang MiaoDepartment of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015, China.
Bi-Cheng ChenKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015, China. bisonch@163.com.
Fan-Feng ChenDepartment of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Nanbaixiang, Wenzhou, 325015, Zhejiang, P.R. China. cffkwk@126.com.

Funding

Wenzhou Municipal Science and Technology Bureau Y2020386
6 · The paper itself

Abstract

purposeThis study aims to evaluate outcomes in patients with mesenteric artery embolism (MAE) who received primary endovascular therapy (EVT) or laparotomy, and investigate risk factors for 30-day mortality.

methodsA retrospective analysis of 94 MAE patients who underwent two different treatment strategies was undertaken. An inverse probability of treatment weighting (IPTW) method was used to balance the confounding effects of baseline clinical data. Logistic regression analysis was performed to compare the outcomes according to type of treatment regimens before and after IPTW. Univariate and multivariable analysis were conducted to determine the risk factors for 30-day mortality.

resultsTwenty-eight MAE patients received primary EVT, and 66 Open Surgery (OS). Logistic regression analysis showed that there was no significant difference between the EVT and OS group in 30-day mortality rate before (odds ratio [OR] 0.477, 95% confidence interval [CI] 0.170 to 1.340, P = 0.160), and after IPTW (OR 0.647, 95% CI 0.210 to 1.993, P = 0.449). After IPTW, it revealed that the rates of second-look surgery (OR 36.727, 95% CI 5.407 to 249.458, P < 0.001) and hospital stay [> 30 days] (OR 0.006, 95% CI 0.000 to 0.363, P = 0.014) were different in the two groups. D-dimer (> 4 mg/L) and procalcitonin (> 0.5 ng/mL) were the independent risk factors for 30-day mortality in MAE patients postoperatively (P < 0.05).

conclusionIn this retrospective study, MAE patients who performed primary EVT had no obvious difference in 30-day mortality rate compared to those who received OS; but it was conducive to reducing prolonged hospital stays. An increase in procalcitonin level and higher D-dimer were associated with short-term poor prognosis in patients with MAE.

Indexed as

Endovascular ProceduresAgedEmbolismFemaleFibrin Fibrinogen Degradation ProductsHumansLaparotomyMaleMesenteric Vascular OcclusionMiddle AgedRetrospective StudiesRisk FactorsTreatment OutcomeFibrin Fibrinogen Degradation Productsfibrin fragment D30-day mortalityEndovascular therapyMesenteric artery embolismOpen surgeryRisk factor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.